Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

3 mg [14C]-A4250

Aliases
3 mg [14C]-A4250 capsule

1 clinical trial

4 indications

Indication
Orphan Cholestatic Liver Diseases
Indication
Progressive Familial Intrahepatic Cholestasis
Indication
Alagille syndrome
Indication
Primary Biliary Cirrhosis
Clinical trial
An Open Label, Single-Dose, Single Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-A4250 in Healthy Male Subjects
Status: Completed, Estimated PCD: 2017-03-08